Basilea Pharmaceutica Ltd. Logo
 

Oncology 2011

 
 
 

Research

American Association of Cancer Research AACR 102nd Annual Meeting 2011, April 2011, Orlando, United States of America

  • 1347 / BAL101553: An optimized prodrug of the microtubule destabilizer BAL27862 with superior antitumor activity. Pohlmann J, Bachmann F, Schmitt-Hoffmann A, Gebhardt K, Spickermann J, Nuoffer C, Biringer G, O'Reilly T, Pruschy M, Lane HA.
  • 743 / Development of tumor models resistant to the novel microtubule destabilizer BAL27862 (active moiety of the prodrug BAL101553). Bachmann F, Danel F, Burger K, Martinez R, Reinelt S, Page M, Steinmetz M, Lane HA.
 
Info